figshare
Browse
12933_2021_1300_MOESM1_ESM.docx (62.81 kB)

Additional file 1 of Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes

Download (62.81 kB)
journal contribution
posted on 2021-05-11, 03:56 authored by V. Sciannameo, P. Berchialla, A. Avogaro, G. P. Fadini
Additional file 1: Table S1. REWIND. Table S2. SUSTAIN-6. Table S3. DECLARE HHF/CVD. Table S4. DECLARE MACE. Table S5. EMPA-REG. Table S6. LEADER. Table S7. PIONEER-6. Table S8. TECOS. Table S9. SAVOR-TIMI. Table S10. EXCEL.

Funding

Società Italiana di Diabetologia

History

Usage metrics

    Cardiovascular Diabetology

    Categories

    Keywords

    CVOT stratum-specific effectsEMPA-REGDPP -4 inhibitorsTECOS2DDECLAREstratum-specific treatment effectsLEADERSUSTAINtype 2 diabetesoutcome trial effectsMACEPIONEER -6target populationpost-stratification HR estimateEXSCELtype 2 diabetes Abstract Background...

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC